Cogentix Medical, Inc. Sustainability Profile
Cogentix Medical, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2010, the company has established itself as a leader in developing innovative solutions for urological and gynaecological conditions. With a focus on minimally invasive procedures, Cogentix Medical offers unique products such as the Urgent® PC Neuromodulation System, which stands out for its efficacy in treating overactive bladder. The company operates primarily in North America, with a growing presence in international markets. Notable achievements include the successful integration of advanced technologies that enhance patient outcomes and streamline clinical workflows. Cogentix Medical's commitment to quality and innovation positions it as a trusted partner in the healthcare sector, dedicated to improving the lives of patients through cutting-edge medical solutions.
DitchCarbon Score
How does Cogentix Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cogentix Medical, Inc.'s score of 18 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cogentix Medical, Inc.'s reported carbon emissions
Cogentix Medical, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company is classified as a current subsidiary, and any potential emissions data or climate commitments may be cascaded from its parent organisation. However, as of now, there are no specific emissions figures or climate pledges documented. In the absence of direct emissions data, it is important to note that many companies in the medical technology sector are increasingly focusing on sustainability and climate commitments. This includes setting science-based targets and engaging in initiatives aimed at reducing their carbon footprint. Cogentix Medical, Inc. may align with these industry trends, but specific details regarding their climate commitments or emissions reduction strategies remain unspecified.
How Carbon Intensive is Cogentix Medical, Inc.'s Industry?
How Carbon Intensive is Cogentix Medical, Inc.'s Location?
Cogentix Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cogentix Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
